76338-90-4

Basic information

• Product Name: (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR
• Synonyms: (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR;2-AMINO-4-BROMOBUTYRIC ACID HYDROBROMIDE;2-Amino-4-bromobutanoic acid hydrobromide
• CAS NO: 76338-90-4
• Molecular Formula: BrH*C₄H₈BrNO₂
• Molecular Weight: 262.93
• Product Categories: pharmacetical
• Mol File: 76338-90-4.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR(76338-90-4)
• EPA Substance Registry System: (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR(76338-90-4)

Safety Data

• Hazardous Substances Data: 76338-90-4(Hazardous Substances Data)

Usage

General Description

(+/-)-2-Amino-4-bromobutanoic acid HBR is a chemical compound with the molecular formula C4H8BrNO2. It is a derivative of 4-bromobutyric acid and is a white crystalline powder. (+/-)-2-AMINO-4-BROMOBUTANOIC ACID HBR is used as a starting material in the synthesis of pharmaceuticals, specifically antiepileptic drugs. It is also used in the production of various other organic compounds. This chemical is classified as a hazardous substance and should be handled with care, as it may cause skin and eye irritation. Additionally, it should be stored in a cool, dry place away from sources of ignition.

InChI:InChI=1/C4H8BrNO2.BrH/c5-2-1-3(6)4(7)8;/h3H,1-2,6H2,(H,7,8);1H

Upstream product

• 6305-38-0 α-amino-γ-butyrolactone hydrobromide 
• 13602-48-7 3-benzoylamino-dihydro-furan-2-one 

Downstream Products

• 2835-81-6 2-aminobutanoic acid 
• 1927-25-9 DL-Homoserine 
• 100606-81-3 2-amino-4-chloro-butyric acid methyl ester; hydrochloride 
• 76338-91-5 2-<(benzyloxycarbonyl)amino>-4-bromobutanoic acid methyl ester 
• 58611-63-5 α-Amino-γ-brombuttersaeure-benzylester 

Relevant articles and documents

DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES

Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.

ALPHA-SUBSTITUTED N-SULFONYL GYLCINE AMIDES ANTAGONISTS OF CCR10, COMPOSITIONS CONTAINING THE SAME AND METHODS FOR USING THEM

Disclosed is a compound of formula (I). Wherein R1, R2 Ar and Cy are as defined herein, or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions of the compound of formula (I), methods of making t

Cyclic hydroxamates, especially multiply substituted [1,2]oxazinan-3-ones

Routes to putative N-acyl-D-ala-D-ala surrogates, beginning with the conversion of 4-, 5-, and 6-membered lactones into 5-, 6-, and 7-membered cyclic hydroxamates, are reported. The key step of the synthesis is trimethylaluminium-promoted cyclization of an ω-aminooxyester. The 7-membered cyclic hydroxamate crystallizes in a chair conformation. Extension of the reaction sequence to homoserine or homoserine lactone leads to cyclocanaline and N-acylated cyclocanalines. The 4-phenylacetamido derivative of cyclocanaline crystallizes in a boat conformation. The attachment of a 2-carboxypropyl substituent to the ring nitrogen of a 4-acylaminocyclocanaline has been effected, prior to cyclization, by coupling of the acyclic aminooxyester precursor to the triflate of benzyl lactate or, after cyclization, by coupling to tert-butyl α-bromopropionate in the presence of potassium fluoride - alumina, followed by removal of the protecting group in each case. A six-membered homolog of the antibiotic lactivicin has been synthesized by the reaction of 4-phenylacetamidocyclocanaline with benzyl 2-oxoglutarate in the presence of carbodiimide, followed by hydrogenolysis. Starting with methyl 2,4-dibromo-2,4-dideoxy-L-erythronate, which is available in two steps from L-ascorbic acid, these reaction sequences have been applied to the stereospecific synthesis of a D-alanine derivative whose nitrogen atom is enclosed within a 3,4-disubstituted [1,2]oxazinan-3-one.